Serum peptidome profiling in patients with gastric cancer

Clinical and Experimental Medicine

Volumn 12, Issue 2, 2012, Pages 79-87

  Yang, Juan ^a,b   Song, Yong Chun ^a   Dang, Cheng Xue ^a   Song, Tu Sheng ^a,b   Liu, Zhi Gang ^a   Guo, You Min ^a   Li, Zong Fang ^a,b   Huang, Chen ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Gastric cancer; Healthy controls; Magnetic beads; MALDI TOF MS; Serum peptidome pattern profiling

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ALGORITHM; ARTICLE; CANCER STAGING; COMPUTER PROGRAM; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; STOMACH CANCER;

ADULT; AGED; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PROTEOME; SENSITIVITY AND SPECIFICITY; SERUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS;

EID: 84861482966     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0149-2     Document Type: Article

References (38)

1. Lam KWK, Lo SCL (2008) Discovery of diagnostic serum biomarkers of gastric cancer using proteomics. Proteomics Clin Appl 2:219-228 (PMID: 21136826)
2. Li JJ, Qi RZ, Ng GKH, Xie D (2009) Proteomics in gastric cancer research: benefits and challenges. Proteomics Clin Appl 3:185-196
3. Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12(1):17-20 (PMID: 16440411)
4. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362:305-315 (PMID: 12892963) (Pubitemid 36936845)
5. Ebert MPA, Niemeyer D, Deininger SO, Wex T, Knippig C, Hoffmann J, Sauer J, Albrecht W, Knippig P, Rolcken C (2006) Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J Proteome Res 5:2152-2158 (PMID: 16944926) (Pubitemid 44330807)
6. Otsuka A, Yohmiya Y, Noha N (2004) Usefulness of magnifying endoscopy in the diagnosis of early gastric cancer. Endoscopy 36(2):165-169 (PMID: 14765314)
7. Ebert MPA, Lamer S, Meuer J, Malfertheiner P, Reymond M, Buschmann T, Rolcken C, Seibert V (2005) Identification of the thrombin light chain A as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis. J Proteome Res 4:586-590 (PMID:15822938) (Pubitemid 40548167)
8. Oue N, Sentanil K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, Anami K, Motoshital J, Ito M, Tanaka S, Yoshida K, Yasui W (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a sensitive biomarker for gastric cancer patients. Int J Cancer 125:2383-2392 (PMID:19670418)
9. Petricoin EF, Zoon K, Kohn ES, Barrett JC, Liotta LA (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat Rev 1:683-695 (PMID:12209149) (Pubitemid 37361543)
10. Petricoin E III, Liotta L (2003) Mass spectrometry - based diagnostics: the upcoming revolution in disease detection. Clin Chem 49:533 (PMID:12651801)
11. Wang CL, Liao PC, Chen CD, Liang Y, Chuang WY, Tsai YH, Chen HC, Chang YS, Yu JS, Wu CC, Yu CJ (2009) Discovery of retinoblastoma - associated binding protein 46 as a novel prognosis marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res 8:4428-4440 (PMID:19655816)
12. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577 (PMID:11867112) (Pubitemid 34178440)
13. Pusch W, Flocco MT, Leung SM, Thiele H (2003) Mass spectrometry-based clinical proteomics. Pharmacogenomics 4:463-476 (PMID:12831324) (Pubitemid 36857180)
14. Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez JC (2003) A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 3:1486-1494 (PMID:12923774) (Pubitemid 37048074)
15. Liang Y, Fang M, Li J, Liu CB, Rodd JA, Kung HF, Yew DTW (2006) Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 81:176-180 (PMID:16828742) (Pubitemid 44780734)
16. Ren H, Du N, Liu G, Hu HT, Tian W, Deng ZP, Shi JS (2006) Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol 12:2789-2792 (PMID:16718772) (Pubitemid 43796495)
17. Poon TCW, Sung JJY, Chow SM, Ng EKW, Yu ACW, Chu ESH, Hui AMY (2006) Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 130:1858-1864 (PMID: 16697748)
18. Su Y, Shen J, Qian H, Ma H, Ji J, Ma L, Zhang W, Meng L, Li Z, Wu J, Jin G, Zhang J, Shou C (2007) Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Sci 98:37-43 (PMID:17052262) (Pubitemid 44803918)
19. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P (2003) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560-1570 (PMID:15018552) (Pubitemid 38338398)
20. Diamandis EP (2003) Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49:1272-1275 (PMID:12881441)
21. Diamandis EP (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96:353-356 (PMID:14996856)
22. Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 3:367-378 (PMID:14990683)
23. Diamandis EP, van der Merwe DE (2005) Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations. Clin Cancer Res 11:963-965 (PMID:15709159) (Pubitemid 40175741)
24. Palmblad M, Tiss A, Cramer R (2009) Mass spectrometry in clinical proteomics - from the present to the future. Proteomics Clin Appl 3:6-17 (PMID:21136932)
25. Ramachandran N, Srivastava S, LaBaer J (2008) Applications of protein microarrays for biomarker discovery. Proteomics Clin Appl 2:1444-1459 (PMID:21136793)
26. Chang WC, Hsu PI, Chen YY, Hsiao M, Lu PJ, Chen CH (2008) Observation of peptide differences between cancer and control in gastric juice. Proteomics Clin Appl 2:55-62 (PMID:21136779) (Pubitemid 351210916)
27. Diamandis EP (2006) Peptidomics for cancer diagnosis: present and future. J Proteome Res 5:2079-2082 (PMID:16944917)
28. Liotta LA, Petricoin EF (2006) Serum peptidome for cancer detection: spinning biological trash into diagnostic gold. J Clin Invest 116:26-30 (PMID:16395400) (Pubitemid 43121786)
29. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116:271-284 (PMID:16395409) (Pubitemid 43121812)
30. Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, Ceglarek U (2007) Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 53:421-428 (PMID:17272489) (Pubitemid 46447938)
31. Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, Feliberti EC, Perry RR, Drake RR (2009) Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg 208:970-978 (PMID:19476873)
32. Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, Jakse G, Henkel C (2009) Serumproteomic profiling in patients with bladder cancer. Eur Urol 56:989-999 (PMID: 19282097)
33. Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 7:230-240 (PMID:16510332) (Pubitemid 43286453)
34. Bergen HR, Vasmatzis G, Cliby WA, Johnson KL, Oberg AL, Muddiman DC (2003) Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry. Dis Markers 19:239-249 (PMID:15266667) (Pubitemid 38869703)
35. Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom H, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA, Goldman R (2006) Enrichment of low molecular weight fraction of serum for mass spectrometric analysis of peptides associated with hepatocellular carcinoma. Proteomics 6:2895-2902 (PMID: 16586431)
36. Liu WT, Gao X, Cai Q, Li JF, Zhu ZL, Li C, Yao XX, Yang QM, Xiang M, Yan M, Zhu ZG (2010) Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci 2:961-971 (PMID: 20515767)
37. Gao X, Liu WT, Yang QM, Liu BY, Cai Li, Li JF, Zhu ZL, Xiang M, Yan M, Zhu ZG (2010) Proteomic profiling of gastric cancer in serum using magnetic bead based sample fractionation and MALDI-TOF-MS. Chin J Clin Oncol 16:933-936
38. Li T, Shen HM (2009) Screen tumor specific biomarkers of gastric cancer in serum using magnetic bead based sample fractionation and MALDI-TOFMS. Modern Oncol 17:1513-1515